Why Cryopreservation is No Longer Science Fiction with Until Co-founder and CEO Laura Deming
Episode
30 min
Read time
2 min
Topics
Productivity, Investing, Startups
AI-Generated Summary
Key Takeaways
- ✓Ice Formation Physics: Cryopreservation success depends on traversing the danger zone between zero and minus 130 degrees Celsius without ice nucleation. Ice formation is stochastic, not deterministic, allowing probabilistic control through cooling rates and cryoprotective agents. Faster cooling and rewarming reduces required chemical concentrations, trading engineering solutions for biological toxicity problems in tissue preservation.
- ✓Proven Scalability Foundation: Human embryos have been successfully cryopreserved for over 30 years and revived to create viable pregnancies. Academic research demonstrates reversible kidney cryopreservation in rats, where animals with single preserved kidneys return to normal function after one month. The core scientific question is not whether preservation works, but how to scale from hundreds of cells to complex organs and whole bodies.
- ✓Organ Transplant Transformation: Current transplant patients must remain within two-hour radius of surgery centers, unable to travel or plan their lives while waiting. Organs expire rapidly, forcing last-minute matching decisions and surgeons to operate immediately after overnight flights. Removing time constraints allows optimal patient-organ matching, scheduled surgeries, and eliminates the frequent problem of patients missing available organs due to logistics.
- ✓Engineering-Biology Tradeoff: Temperature provides a unique conceptual lever in biology where physics equations actually apply to model molecular behavior. Teams can reduce biological challenges like cryoprotective agent toxicity by improving engineering solutions for faster, more uniform cooling and rewarming. This engineering-biology substitutability distinguishes cryopreservation from most biological problems where only therapeutic approaches work.
- ✓Medical Hibernation Timeline: Until targets near-term organ preservation for transplants as proof of concept before whole-body applications. The technology addresses cases where patients miss life-saving treatments by months, like metastatic melanoma therapies that shifted survival from six months to over a decade. Brain preservation remains the largest unknown for whole-body protocols, requiring research into acceptable neural tissue injury levels.
What It Covers
Laura Deming, founder of Until, explains how reversible cryopreservation technology works to pause biological time for organs and potentially whole bodies. The company targets organ transplant logistics first, then aims for medical hibernation to bridge patients to future cures, addressing scientific challenges around ice formation and tissue preservation.
Key Questions Answered
- •Ice Formation Physics: Cryopreservation success depends on traversing the danger zone between zero and minus 130 degrees Celsius without ice nucleation. Ice formation is stochastic, not deterministic, allowing probabilistic control through cooling rates and cryoprotective agents. Faster cooling and rewarming reduces required chemical concentrations, trading engineering solutions for biological toxicity problems in tissue preservation.
- •Proven Scalability Foundation: Human embryos have been successfully cryopreserved for over 30 years and revived to create viable pregnancies. Academic research demonstrates reversible kidney cryopreservation in rats, where animals with single preserved kidneys return to normal function after one month. The core scientific question is not whether preservation works, but how to scale from hundreds of cells to complex organs and whole bodies.
- •Organ Transplant Transformation: Current transplant patients must remain within two-hour radius of surgery centers, unable to travel or plan their lives while waiting. Organs expire rapidly, forcing last-minute matching decisions and surgeons to operate immediately after overnight flights. Removing time constraints allows optimal patient-organ matching, scheduled surgeries, and eliminates the frequent problem of patients missing available organs due to logistics.
- •Engineering-Biology Tradeoff: Temperature provides a unique conceptual lever in biology where physics equations actually apply to model molecular behavior. Teams can reduce biological challenges like cryoprotective agent toxicity by improving engineering solutions for faster, more uniform cooling and rewarming. This engineering-biology substitutability distinguishes cryopreservation from most biological problems where only therapeutic approaches work.
- •Medical Hibernation Timeline: Until targets near-term organ preservation for transplants as proof of concept before whole-body applications. The technology addresses cases where patients miss life-saving treatments by months, like metastatic melanoma therapies that shifted survival from six months to over a decade. Brain preservation remains the largest unknown for whole-body protocols, requiring research into acceptable neural tissue injury levels.
Notable Moment
Deming reveals her childhood misconception that everyone lived to exactly ten years old before dying instantly, which sparked her interest in aging. This misunderstanding made longevity seem more tractable than if lifespans were fixed, since the uncertainty around death timing suggested underlying factors could potentially be modified through scientific intervention.
Episode Transcript
What if you could take someone who is on their deathbed and find some way to hibernate them until the sort of critical cure for their disease comes online? The ability to freeze time for humans. I didn't actually think that was something you could go work on, so apparently it is. Our long term goal is reversible whole body cryopreservation for medical hibernation. But in the near term, what we work on is reversely cryopreserving single human organs to help transplant patients get organs more efficiently. Making time not a variable changes the whole paradigm. One thing I love about the field of cryopreservation is I think, like, the problem speaks for itself. Water expands when it forms ice. That's just hard for your tissue to take without substantial damage. And the cool thing is that there's sort of a temperature reverse and you can get below that without ice formation, then you're good. We already reversibly cryopreserved tissue including human tissue all the time, and we do it for very long time periods. There are kids who were literally cryopreserved for thirty years years as tiny embryos. And so the main question is not, is this possible to do at all? It's is it possible to scale up? Given that's true, why don't you think it's been worked on? Hi, listeners. Welcome back to No Priors. Today, I'm really excited to be here with Laura Deming, previously the founder of the Longevity Fund and now the cofounder and CEO of Until. We're gonna talk about how Until is progressing the frontier of reversible cryopreservation or freezing living things and waking them back up, beginning with human organs progressing to small animals and hopefully making progress on the whole body. It sounds like science fiction, but we'll talk about some of the scientific challenges, where we are today, and the implications if this is possible. Thanks so much. Welcome, Laura. Laura, thanks so much for doing this. Yeah. Thanks for having me. I've been so looking forward to this since our Pantheon watch sessions. We're talking about upload and the nature of consciousness. But one thing that you don't know is that my, like, very long ago wished for technologies that I wanted to exist were telepathy and, like, upload and the ability to to to freeze time for humans. I didn't actually think that was something you could go work on. So, apparently, it is. How do you end up working on that or being interested in longevity at all? There there's two different questions. So, yeah, I come from longevity background, but in my mind, like, reversible cryo preservation is is applicable a bit outside of that as well. I don't know. I mean, I I think I'm really obsessed with areas that feel like they should be worked on but aren't. And, you know, when I was a kid, I think naively just growing up that seemed really obvious for longevity. And it's really surprising to …
Get the full transcript (6,989 words) + summary by email — free
One-time email with the complete transcript and AI summary of this episode. No account needed.
One email, no spam. We’ll also show you what SignalCast does.
Browse all No Priors: Artificial Intelligence | Technology | Startups transcripts →
You just read a 3-minute summary of a 27-minute episode.
Get No Priors: Artificial Intelligence | Technology | Startups summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from No Priors: Artificial Intelligence | Technology | Startups
Redefining Chip Architecture with Arm CEO Rene Haas
Sep 3 · 37 min
This Week in Startups
Neurosymbolic AI outperforms chatbots and product search | E2327
Aug 19
More from No Priors: Artificial Intelligence | Technology | Startups
Rethinking Legacy Data Infrastructure with Eon Co-Founders Ofir Ehrlich and Gonen Stein
Aug 27 · 34 min
20VC (20 Minute VC)
20VC: Leo Aschenbrenner's Largest Holding: Inside the $90BN Bloom Energy | Why Electricity, Not AI Models, Will Decide the Winners of the AI Race | Why We Are Not in an AI Capex Bubble | Energy Sovereignty and The Future of Power with KR Sridhar
Jun 29
More from No Priors: Artificial Intelligence | Technology | Startups
We summarize every new episode. Want them in your inbox?
Redefining Chip Architecture with Arm CEO Rene Haas
Rethinking Legacy Data Infrastructure with Eon Co-Founders Ofir Ehrlich and Gonen Stein
From Restoring Sight to Reimagining the Brain, with Max Hodak
What Chess.com Teaches US About Superhuman Capabilities, with CEO Erik Allebest
Chasing Trillion-Dollar Companies, Founder Ambition, Token Budgets, and Regulatory Capture with Sarah & Elad
Similar Episodes
Related episodes from other podcasts
This Week in Startups
Aug 19
Neurosymbolic AI outperforms chatbots and product search | E2327
20VC (20 Minute VC)
Jun 29
20VC: Leo Aschenbrenner's Largest Holding: Inside the $90BN Bloom Energy | Why Electricity, Not AI Models, Will Decide the Winners of the AI Race | Why We Are Not in an AI Capex Bubble | Energy Sovereignty and The Future of Power with KR Sridhar
Masters of Scale
Jun 2
The race no one can win: AI’s anti-human crisis, with Aza Raskin
This Week in Startups
May 27
The Drone Company Quietly Taking Over Delivery
Beyond Biotech
Apr 30
How Epic Bio is leveraging CRISPR without cutting DNA
Explore Related Topics
This podcast is featured in Best AI Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's Investing & Markets Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into No Priors: Artificial Intelligence | Technology | Startups.
Every Monday, we deliver AI summaries of the latest episodes from No Priors: Artificial Intelligence | Technology | Startups and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime